Deep Genomics alternatives and competitors
The closest alternatives to Deep Genomics are Lila Sciences, Cellarity, Chemify and Xaira Therapeutics.
Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease.
10 alternatives to Deep Genomics
What each product does, with its price as the vendor publishes it.
-
L
Lila Sciences makes very large claims about what its platform can do, and as of September 2026 it has begun publishing evidence for some of them.
Price: No published price
-
C
Cellarity is a Flagship Pioneering company in Somerville, Massachusetts, founded in 2019, that designs drugs against the behavior of a whole cell rather than against a molecular target.
Price: Not applicable
-
C
Chemify makes the molecules it designs, in a laboratory it built itself. Rather than handing a design to somebody with a laboratory, it is trying to turn its own laboratory into a printer.
Price: No published price
-
X
South San Francisco company founded in 2023 and launched publicly in April 2024 with more than $1 billion in committed funding, co led by ARCH Venture Partners and Foresite Labs.
Price: Not applicable
-
P
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
Price: No published price
-
I
Immunai occupies a different position from most of this category. It is not developing its own drugs.
Price: No published price
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
I
Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines.
Price: No published price
-
R
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
Price: Not applicable
-
P
Protein design company in Emeryville, California, built on the ProGen family of protein language models, which grew out of research first showing that large language models can generate functional proteins across diverse families, published in Nature Biotechnology in 2023.
Price: OpenCRISPR-1 free to license, other terms not published
Deep Genomics alternatives, answered
What are the best alternatives to Deep Genomics?
The closest alternatives to Deep Genomics are Lila Sciences, Cellarity, Chemify, Xaira Therapeutics and PostEra. Lila Sciences makes very large claims about what its platform can do, and as of September 2026 it has begun publishing evidence for some of them. Cellarity is a Flagship Pioneering company in Somerville, Massachusetts, founded in 2019, that designs drugs against the behavior of a whole cell rather than against a molecular target. Chemify makes the molecules it designs, in a laboratory it built itself.
Who are Deep Genomics's competitors?
Deep Genomics's competitors in the Drug Discovery AI category include Lila Sciences, Cellarity, Chemify, Xaira Therapeutics, PostEra and Immunai.